Platelet aggregation response to cyclooxygenase inhibition and thromboxane receptor antagonism using impedance aggregometry: A pilot study
Physiological Reports · 2024
DOI: 10.14814/phy2.70002 ↗At a glance
Journal article in Physiological Reports, 2024. Written by Auni C Williams and 3 co-authors. Institution: Noll Laboratory, Department of Kinesiology, The Pennsylvania State University, University Park, Pennsylvania, USA. Major MEDLINE topics: Platelet Aggregation, Cyclooxygenase Inhibitors, Aspirin, Receptors, Thromboxane. Cited 3 times so far (Crossref); 12 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIA NIH HHS, HHS | NIH | National Institute on Aging (NIA), HHS | National Institutes of Health (NIH).
Abstract (original language)
Impedance aggregometry is an alternative to light transmission aggregometry that allows analysis of platelet function in whole blood samples. We hypothesized (1) impedance aggregometry would produce repeatable results, (2) inhibition of cyclooxygenase with aspirin would attenuate aggregation responses to collagen and abolish the aggregation response to arachidonic acid (AA), and (3) thromboxane receptor antagonism (terutroban) would attenuate the aggregation response to AA. Venous blood was obtained from 11 participants three times separated by at least 2 weeks. One sample followed 7‐day‐aspirin intervention (81 mg once daily; ASA), the others no intervention (control). Aggregation was induced using 1 μg/mL collagen ([col 1]), 5 μg/mL collagen ([col 5]), and 50 mM AA via impedance aggregometry to determine total aggregation (AUC) analyzed for intra‐test repeatability, inter‐test repeatability, intervention (ASA or control), and incubation (saline or terutroban). [col 1] showed high intra‐test ( p ≤ 0.03 visit 1 and 2) and inter‐test repeatability ( p < 0.01). [col 5] and AA showed intra‐ ([col 5] p < 0.01 visit 1 and 2; AA p < 0.001 visit 1 and 2) but not inter‐test repeatability ([col 5] p = 0.48; AA p = 0.06). ASA attenuated AUC responses to [col 1] ( p < 0.01), [col 5] ( p = 0.03), and AA ( p < 0.01). Terutroban attenuated AUC in response to AA ( p < 0.01). [col 1] shows sufficient repeatability for longitudinal investigations of platelet function. [col 5] and AA may be used to investigate mechanisms of platelet function and metabolism at a single time point.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Noll Laboratory, Department of Kinesiology, The Pennsylvania State University, University Park, Pennsylvania, USA.
- Center for Healthy Aging, The Pennsylvania State University, University Park, Pennsylvania, USA.
ORCID profiles: Auni C Williams
Funding
- NIA NIH HHS
- HHS | NIH | National Institute on Aging (NIA)
- HHS | National Institutes of Health (NIH)
- NHLBI NIH HHS
- National Institute on Aging
- National Institutes of Health
Cite
APA
Williams, A. C., Fisher, K. G., Alexander, L. M., & Kenney, W. L. (2024). Platelet aggregation response to cyclooxygenase inhibition and thromboxane receptor antagonism using impedance aggregometry: A pilot study. Physiological Reports. https://doi.org/10.14814/phy2.70002
Vancouver
Williams AC, Fisher KG, Alexander LM, Kenney WL. Platelet aggregation response to cyclooxygenase inhibition and thromboxane receptor antagonism using impedance aggregometry: A pilot study. Physiological Reports. 2024. doi:10.14814/phy2.70002
BibTeX
@article{Williams2024,
author = {Williams, Auni C and Fisher, Kat G and Alexander, Lacy M and Kenney, W Larry},
title = {Platelet aggregation response to cyclooxygenase inhibition and thromboxane receptor antagonism using impedance aggregometry: A pilot study},
journal = {Physiological Reports},
year = {2024},
doi = {10.14814/phy2.70002}
}
EUVIMED